Actionnariat et activité des initiés pour Mesa Laboratories, Inc. (MLAB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $125.29 |
| Capitalisation | $701M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-09 | Capone Mark Christopher | A-Award | 2,423 | |
| 2026-09-09 | Ladiwala Shiraz Shabanali | A-Award | 2,510 | |
| 2009-09-09 | Alltoft Jennifer Sadie | A-Award | 1,774 | |
| 2026-09-09 | Hall Shannon | A-Award | 1,774 | |
| 2026-09-09 | Sullivan John James | A-Award | 1,774 | |
| 2026-09-09 | Tripeny R Tony | A-Award | 1,774 | |
| 2026-08-15 | Capone Mark Christopher | M-Exempt | 2,784 | |
| 2026-08-15 | Capone Mark Christopher | M-Exempt | 2,784 | |
| 2026-08-15 | Alltoft Jennifer Sadie | M-Exempt | 2,784 | |
| 2026-08-15 | Alltoft Jennifer Sadie | M-Exempt | 2,784 |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $5.8M | $5.5M | $10.2M | $81.4M | $263.9M | $49.3M | $32.9M | $28.2M | $27.3M | $26.9M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $14.3M | $14.3M | $12.5M | $21.1M | $23.8M | $41.2M | $42.6M | $39.1M | $42.0M | $44.1M |
| Stocks | $13.9M | $9.2M | $6.8M | $14.2M | $11.2M | $24.6M | $34.6M | $32.7M | $25.4M | $26.4M |
| Actifs Courants | $35.8M | $32.0M | $33.6M | $122.8M | $303.7M | $124.3M | $119.0M | $109.4M | $102.7M | $106.3M |
| Immobilisations Corporelles | $26.0M | $23.6M | $22.2M | $22.1M | $22.0M | $28.6M | $28.1M | $41.4M | $32.3M | $48.1M |
| Goodwill | $72.2M | $65.5M | $66.4M | $141.5M | $160.8M | $291.2M | $286.4M | $180.1M | $181.8M | $186.9M |
| Actifs Incorporels | $37.8M | $42.9M | $33.2M | $119.9M | $111.7M | $250.1M | $216.8M | $113.8M | $96.9M | $83.3M |
| Actifs Totaux | $171.7M | $164.1M | $156.8M | $420.2M | $601.5M | $707.4M | $661.8M | $446.8M | $433.3M | $427.7M |
| Dettes Fournisseurs | $2.2M | $2.4M | $2.9M | $3.4M | $4.5M | $7.9M | $6.1M | $6.0M | $5.7M | $4.9M |
| Dette à Court Terme | $1.1M | $1.6M | $2.1M | 0 | 0 | 0 | 0 | 0 | $101.0M | $5.6M |
| Passifs Courants | $16.6M | $17.3M | $23.7M | $26.0M | $32.6M | $48.1M | $43.4M | $44.3M | $164.0M | $61.9M |
| Dette à Long Terme | $53.7M | $44.6M | $20.6M | $140.3M | $145.7M | $218.4M | $183.3M | $221.7M | $76.9M | $145.9M |
| Passifs Totaux | $73.9M | $64.7M | $45.5M | $200.2M | $195.2M | $313.6M | $268.4M | $301.4M | $273.5M | $241.5M |
| Réserves | $73.7M | $68.3M | $73.3M | $71.9M | $72.5M | $76.7M | $74.2M | -$183.5M | -$188.9M | -$185.7M |
| Capitaux Propres | $97.8M | $99.4M | $111.3M | $220.0M | $406.2M | $393.8M | $393.5M | $145.4M | $159.8M | $186.2M |
| Dette Totale | $54.8M | $46.3M | $22.7M | $141.4M | $146.7M | $221.1M | $186.1M | $231.3M | $181.5M | $168.8M |
| Dette Nette | $49.0M | $40.8M | $12.6M | $60.0M | -$117.2M | $171.8M | $153.2M | $203.1M | $154.2M | $141.9M |
| Fonds de Roulement | $19.2M | $14.7M | $10.0M | $96.8M | $271.2M | $76.3M | $75.6M | $65.0M | -$61.3M | $44.4M |
Santé financière
| Dette / Capitaux propres | 0.54 |
| Ratio de liquidité | 2.07 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.45 |
Rentabilité
| Rentabilité des capitaux propres | 2.59% |
| Rentabilité du capital investi | 3.05% |
| Rentabilité des actifs | 1.14% |
| Marge brute | 65.99% |
| Marge opérationnelle | 9.00% |
| Marge nette | 1.92% |
Entreprises liées: BZAI · EGAN · GDEV · GRRR · GRVY · LPTH · MVIS
Explorer le secteur: Healthcare · Medical - Specialties
Plus de sections de MLAB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions